[{"data":1,"prerenderedAt":160},["ShallowReactive",2],{"drug-minoxidil-topical":3},{"id":4,"schemaVersion":5,"name":6,"category":9,"class":10,"brands":13,"synonyms":17,"formulations":22,"regimens":35,"contraindications":58,"warnings":68,"renal":69,"monitoring":70,"interactions":71,"review":72,"examples":75,"atc":81,"iran":83,"links":123,"populations":145,"usApproval":155},"minoxidil-topical",1,{"fa":7,"en":8},"ماینوکسیدیل موضعی","Minoxidil (topical)","dermatology",{"fa":11,"en":12},"محرک رشد مو","Hair regrowth agent",[14],{"name":15,"market":16},"Rogaine","US",[18,19,20,21],"rogaine","ماینوکسیدیل","مینوکسیدیل","ریزش مو",[23],{"id":24,"form":25,"route":26,"label":27,"concentration":28,"markets":30,"refs":31},"foam-5","gel","topical","5% foam",{"amount":5,"unit":29,"perUnit":29},"application",[16],[32],{"source":33,"section":34},"fda-minoxidil","Active ingredient",[36],{"id":37,"disease":38,"label":39,"population":42,"type":46,"unit":29,"dose":47,"refs":48,"notes":51},"hair","alopecia",{"fa":40,"en":41},"ریزش موی ارثی (زنان) — نصف درپوش یک بار در روز روی پوست سر","Female-pattern hair loss — half a capful once daily to the scalp",{"minAge":43},{"value":44,"unit":45},18,"year","fixed",{"perDose":5,"dosesPerDay":5},[49],{"source":33,"section":50},"Directions",[52],{"text":53,"refs":56},{"fa":54,"en":55},"بیشتر یا مکررتر نتیجه بهتری ندارد؛ برای حفظ اثر باید ادامه یابد.","More or more often does not improve results; continued use is needed to keep regrowth.",[57],{"source":33,"section":50},[59],{"id":60,"severity":61,"text":62,"refs":65},"ci","block",{"fa":63,"en":64},"ریزش ناگهانی یا سکه‌ای، بدون سابقه خانوادگی، یا پس از زایمان؛ پوست سر قرمز یا ملتهب.","Sudden or patchy loss, no family history, or after childbirth; red or inflamed scalp.",[66],{"source":33,"section":67},"Do not use",[],[],[],[],{"status":73,"reviewer":74,"date":74},"unverified",null,[76],{"regimen":37,"formulation":24,"input":77,"expect":80},{"ageYears":78,"weightKg":79},35,60,{"perDose":5},[82],"D11AX01",{"status":84,"forms":85,"refs":118},"registered",[86,90,94,98,102,106,110,114],{"code":87,"en":88,"fa":89},"00856","MINOXIDIL 2% 60ML TOP SOL","محلول موضعی ماینوکسیدیل ۲ درصد ۶۰ میلی‌لیتر",{"code":91,"en":92,"fa":93},"21809","MINOXIDIL 2% AEROSOL FOAM","فوم ماینوکسیدیل ۲ درصد",{"code":95,"en":96,"fa":97},"01829","MINOXIDIL 5% 60ML TOP SOL","محلول موضعی ماینوکسیدیل ۵ درصد ۶۰ میلی‌لیتر",{"code":99,"en":100,"fa":101},"21810","MINOXIDIL 5% AEROSOL FOAM","فوم ماینوکسیدیل ۵ درصد",{"code":103,"en":104,"fa":105},"01593","MINOXIDIL COMPOUND TOP SOLUTION","محلول ماینوکسیدیل ترکیبی",{"code":107,"en":108,"fa":109},"00854","MINOXIDIL_BULK","ماده اولیه ماینوکسیدیل",{"code":111,"en":112,"fa":113},"52817","MINOXIDIL SOLUTION TOPICAL 20 mg\u002F1mL 50 mL","محلول موضعی ماینوکسیدیل ۲۰ میلی‌گرم \u002F ۱ میلی‌لیتر ۵۰ میلی‌لیتر",{"code":115,"en":116,"fa":117},"52818","MINOXIDIL SOLUTION TOPICAL 50 mg\u002F1mL 50 mL","محلول موضعی ماینوکسیدیل ۵۰ میلی‌گرم \u002F ۱ میلی‌لیتر ۵۰ میلی‌لیتر",[119],{"source":120,"section":121,"url":122},"darooyab-generic","G-4581\u002FMinoxidil-Topical","https:\u002F\u002Fwww.darooyab.ir\u002FG-4581\u002FMinoxidil-Topical",[124,128,132,136,139,142],{"kind":125,"url":126,"label":127},"fda","https:\u002F\u002Fwww.accessdata.fda.gov\u002Fscripts\u002Fcder\u002Fdaf\u002Findex.cfm?event=overview.process&ApplNo=021812","NDA021812",{"kind":129,"url":130,"label":131},"dailymed","https:\u002F\u002Fdailymed.nlm.nih.gov\u002Fdailymed\u002FdrugInfo.cfm?setid=4d328537-b7f5-43cc-9837-c5a0c6c390f8","FDA Rogaine women (OTC)",{"kind":133,"url":134,"label":135},"medlineplus","https:\u002F\u002Fmedlineplus.gov\u002Fdruginfo\u002Fmeds\u002Fa682608.html","Minoxidil",{"kind":133,"url":137,"label":138},"https:\u002F\u002Fmedlineplus.gov\u002Fdruginfo\u002Fmeds\u002Fa689003.html","Minoxidil Topical",{"kind":140,"url":141,"label":82},"who-atc","https:\u002F\u002Fatcddd.fhi.no\u002Fatc_ddd_index\u002F?code=D11AX01",{"kind":143,"url":122,"label":144},"darooyab","Minoxidil-Topical",{"pregnancy":146},{"level":147,"quote":148,"text":149,"refs":152},"caution","مصرف در بارداری ماینوکسیدیل-موضعی گروه C در شرايط خاص و نظارت ويژه پزشك قابل استفاده است:",{"fa":150,"en":151},"دارویاب: گروه C — فقط اگر فایده بیشتر از خطر باشد.","Darooyab: category C — only if benefit outweighs risk.",[153],{"source":120,"section":154,"url":122},"G-4581\u002FMinoxidil-Topical — مصرف در بارداری",{"kind":156,"refs":157,"id":127},"NDA",[158],{"source":33,"section":159},"SPL approval \u002F marketing category",1792444704289]